eipa

EIPA (L593754) is a TRPP3 channel inhibitor (IC50=10.5 μM) and an inhibitor of Na+/H+ exchange (NHE). EIPA inhibits megacytosis, promotes autophagy, and can be used in inflammation and tumor studies.

EIPA hydrochloride also inhibits Na+/H+-exchanger (NHE) and macropinocytosisEIPA hydrochloride (L593754 hydrochloride) is a TRPP3 channel inhibitor with an IC50 of 10.5 μM.

Geiparvarin is an anticancer agent that acts as an inhibitor of MAO-B (pIC50= 6.84 μM). It exerts its antitumor effects by downregulating COX2 expression and inhibiting angiogenesis. Geiparvarin halts the cell cycle at the G1 phase and induces apoptosis in cancer cells. Additionally, it exhibits antimicrotubule activity (Microtubule/Tubulin) and disrupts the cytoskeleton, contributing to its antiproliferative properties. Geiparvarin is of research interest for its potential effects on lung cancer, leukemia, and breast cancer.